Business | Stone Law, P.C.

Innovator Organizations Applaud Delrahim Action on SEPs, Plead for Restoration of Injunctive Relief for Infringement

March 18, 2019

A number of organizations, including Ericsson, Nokia, Philips, Qualcomm, the Innovation Alliance and the Licensing Executives Society, have sent two separate letters to U.S. Attorney General William Barr, USPTO Director…

Other Barks & Bites for Friday, March 15

March 15, 2019

Stone Law, P.C.

Business, Copyright, Fair Use, Litigation, Patent, Trademark

This week in Other Barks & Bites: the U.S. Patent and Trademark Office promotes Scott Boalick to Chief Judge of the Patent Trial and Appeal Board (PTAB); the agency also…

Why Huawei is Unlikely to Win Its Case Against the United States

March 13, 2019

Stone Law, P.C.

Business, Litigation, Patent

In an expected move, Huawei filed a lawsuit against the United States in the U.S. District Court for the District of Texas on March 6. Huawei Technologies v. U.S., 4:19-cv-00159,…

House Health Subcommittee Holds Fractious Hearing on Drug Pricing and Patent Protections

March 12, 2019

Stone Law, P.C.

Business, Patent

On the morning of Thursday, March 7, the House Ways & Means Committee’s Subcommittee on Health held a hearing titled Promoting Competition to Lower Medicare Drug Prices. The hearing focused…

EFF Trolls the Patent Office with ‘Save Alice Campaign’

March 11, 2019

Stone Law, P.C.

Business, Litigation, Patent

The Electronic Frontier Foundation (EFF) is at it again, this time with what they refer to as a Save Alice campaign. The EFF does not like the Revised Patent Eligibility…

Post-Myriad Legal and Policy Considerations for Patenting Genetic Inventions

March 10, 2019

Stone Law, P.C.

Business, Litigation, Patent

The U.S. Supreme Court’s 2013 ruling in Association for Molecular Pathology v. Myriad Genetics changed the landscape of what is considered patentable material in the context of genetic inventions. In…

Other Barks & Bites for Friday, March 8

March 8, 2019

Stone Law, P.C.

Business, Copyright, Litigation, Patent, Trademark

This week in Other Barks & Bites: The United Nations highlights the importance of women in innovation on International Women’s Day; Comments due today on USPTO Section 101 Guidance; FDA…

Examining the Truvada #BreakThePatent Debate: Gilead Responds

March 3, 2019

Stone Law, P.C.

Business, Patent

In July 2012, the U.S. Food and Drug Administration (FDA) first approved Truvada, an acquired immunodeficiency syndrome (AIDS) treatment manufactured by Gilead Sciences as a daily pre-exposure prophylactic (PrEP) treatment…

Ten Things to Avoid When Doing Trademark Surveys

March 2, 2019

Stone Law, P.C.

Business, Litigation, Patent, Trademark

Surveys to prove or disprove trademark infringement or likelihood of confusion have been used by attorneys for many years. Unfortunately, many attorneys using surveys can weaken a survey’s impact by…

Other Barks & Bites for Friday, March 1

March 1, 2019

Stone Law, P.C.

Business, Copyright, Litigation, Patent, Trademark

This week in Other Barks and Bites: the Senate Judiciary Committee plans to go after drug patents to promote access to generic medications; Apple faces another patent suit in the…